Johnson & Johnson announced that its subsidiary, Red River Talc, filed a voluntary prepackaged Chapter 11 bankruptcy case in the U.S. Bankruptcy Court for the Southern District of Texas to fully and finally resolve all current and future claims related to ovarian cancer arising from cosmetic talc litigation against the company and its affiliates in the United States. Red River filed the bankruptcy case after it received the support of the overwhelming majority, approximately 83%, of current claimants for the proposed bankruptcy plan. The support far exceeds the 75% approval threshold required by the U.S. Bankruptcy Code to secure confirmation of the Plan. After extensive negotiations with counsel for claimants who initially opposed the Plan, Red River agreed to increase its contribution to the settlement by $1.75B to approximately $8B. The Plan enables a full and final resolution of the Company’s ovarian talc litigation.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- FedEx reports downbeat Q1, Nike vet returns as new CEO: Morning Buzz
- J&J says FDA approves Rybrevant in combination with standard of care chemo
- J&J raises baby powder settlement offer to over $8.2B, Bloomberg says
- Johnson & Johnson participates in a conference call with Cantor Fitzgerald
- AC Immune receives second milestone payment for ACI-35.030
